Replies to post #162 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

I'm happy that RVNC is not pursuing depression, even though RVNC has (licensed) patents on the use of botulinum toxin for mood/depression:

Moreover, $AGN could bump into $RVNC's IP covering mood/depression:https://t.co/rNQmntX4uN

— Roy Friedman (@DewDiligence) April 5, 2017

[scan up]